1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBreast Cancer Research Program (BCRP) is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The DOD BCRP funds innovative, high-impact research to eradicate breast cancer.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Breast Cancer Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Vision – A world without breast cancer Mission – To end breast cancer for Service Members and their Families, Veterans, and the general public by funding innovative, high-impact research through a partnership of scientists and consumers The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer.
seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. BCRP Program Summary Sheet The Breast Cancer Landscape This overview describes what is currently known about the most pertinent topics that are consistent with the BCRP's mission of ending breast cancer.
Applicants are strongly urged to read and consider The Breast Cancer Landscape before preparing their applications.
BCRP Overarching Challenges Considering the current breast cancer landscape and the BCRP's mission to end breast cancer, the BCRP seeks applications that address the following overarching challenges: Prevent breast cancer (primary prevention) Identify determinants of breast cancer initiation, risk, or susceptibility Distinguish deadly from non-deadly breast cancers Conquer the problems of overdiagnosis and overtreatment Identify what drives breast cancer growth; determine how to stop it Identify why some breast cancers become metastatic Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence Revolutionize treatment regimens by replacing them with ones that do all of the following: improve survival, are more effective, and are less toxic Eliminate the mortality associated with metastatic breast cancer Congressional Appropriations Breast Cancer Centers of Excellence Awards Recent Applications Recommended for Funding FY25 Peer Review Participants Breast Cancer Research Stamp $28.
8 million received to date Breast Cancer Research Stamp Program Funded Awards Breast Cancer Research Semipostal $23.
7 million received to date Breast Cancer Stamp Program Booklet University of California, San Francisco Development of an in Vitro Three-Dimensional Cell Culture Model of Clinically Relevant Human Lung Cancer Cancer does not Happen in a Void Kara Kenan, BCRP Peer Reviewer [Click on image to watch] Era of Hope Scholars - Making Breakthroughs in Preventing Metastasis Yibin Kang, PhD; Princeton University; Cyrus Ghajar, PhD; Fred Hutchinson Cancer Research Center [Click on image to watch] FY25 BCRP Recommended for Funding List CDMRP Advances Breast Cancer Care for Military Members and their Families Breast Cancer Research Program Booklet Kara Kenan - Cancer does not Happen in a Void (External Link) CDMRP-FUNDED RESEARCH AIMS TO EFFICIENTLY DETECT BREAST CANCER Programmable Probiotics for Targeted Breast Cancer Therapy Identification of Actionable Networks Promoting Breast Cancer Progression and Brain Metastasis Inhibition of Myeloid-Derived Suppressor Cell Biogenesis to Improve the Efficacy of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Krystle Hensley - BCRP Consumer Reviewer Epigenetic Factor CECR2 as a Potential Target in Breast Cancer Metastasis The CDMRP Remembers Dr. Susan Love Angela K.
Waller - Elevating Survivorship CDMRP-Funded Research Contributed to Test Included in the Defense Health Agency's Pilot Program Dual-Loading Antibody-Drug Conjugates for Combating Breast Cancer Tumor Heterogeneity and Drug Resistance Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize in Chemistry Maria Fowler - Breast Cancer Consumer Reviewer Desiree Walker: Embracing Advocacy on my Breast Cancer Journey Regulation of Breast Cancer Stem Cells by Tissue Rigidity Mechanisms Promoting the Colonization of Breast Cancer Metastases in Bone Advances in BRCA Research Click here to provide feedback/comments to the BCRP Breast Cancer Research Semipostal $23.
7 million received to date Breast Cancer Stamp Program Booklet Last updated Thursday, September 3, 2026
According to the current listing, eligibility includes: Varies by award mechanism. Generally open to scientists, clinicians, and organizations conducting breast cancer research. Specific criteria apply to different award types (e. Confirm the full requirements in the official notice before applying.
Breast Cancer Research Program (BCRP) is funded by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Rare Cancers Research Program (RCRP) Concept Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). The FY26 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation in rare cancers.
Pancreatic Cancer Research Program, Idea Development Award is sponsored by Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). This award mechanism supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements to accelerate progress in improving outcomes for individuals with pancreatic cancer.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article